Eye health

DHA, EPA, and dietary fish may reduce the risk of AMD and related vision loss.

Omega-3 may reduce risk of AMD vision loss

Omega-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) may significantly reduce the risk of developing age-related macular degeneration (AMD), according to new research.

Complaint on Healthspan supplements claims not upheld: ASA

Complaint on Healthspan supplements claims not upheld: ASA

By Jess Halliday

Claim-related complaints about product adverts and brand names of UK mail order supplements firm Healthspan have not been upheld by the Advertising Standards Agency (ASA), as the catalogue contains a disclaimer stating they are not intended to treat,...

HiPPy times for one German company (and potentially others) as EFSA's health claims panel approves an article 14 thiamin claim for neural development in under-3s

EFSA health claim opinion

EFSA approves vitamin B1-infant brain health claim

By Shane Starling

The European Food Safety Authority (EFSA) has approved a health claim linking thiamin (vitamin B1) and “normal neurological development and function” in infants and children up to three years of age.

Some MEPs are calling for a revision of DHA-infant ye development claims

MEPs question omega-3 baby milk benefits

By Shane Starling

Members of the European Parliament (MEPs) are questioning whether omega-3 form DHA can benefit infant eye sight, despite the nutrient winning endorsement from one of the world’s toughest claims assessment agencies – the European Food Safety Authority...

The eyes have it, but the brain

EC hands omega-3 mixed results

By Shane Starling

An article 14 children’s development health claim submitted to the European Union by drug giant Merck linking omega-3 form DHA with infant visual development has been approved at committee level by the European Commission.

Industry is finding the EU health claims system hard to swallow

Are health claims making your business sick?

By Shane Starling

2010 has been another tough year for the European functional food and supplements industries as health claim rejections have continued to flood in, leaving some in a state of high anxiety, fear and dread. Others are just mildly annoyed at a situation...

Infant brain and eye claims are set for EU confirmation

EC to confirm infant and child omega-3 claims

By Shane Starling

A November European Commission standing committee meeting has said four omega-3 brain and vision claims will be confirmed at a meeting in Brussels on December 6, 2010.

The science of eye health ingredients

Special edition: Eye health

The science of eye health ingredients

By Stephen Daniells

In the second part of our special series on eye health, NutraIngredients takes a closer look at the science behind lutein, omega-3 and the other ingredients eyeing a place on the podium for eye health.

EFSA health claims chief: Our methods are misunderstood

EFSA health claims chief: Our methods are misunderstood

By Shane Starling

In part two of this exclusive NutraIngredients podcast, Professor Albert Flynn, chair of European Food Safety Authority’s Scientific Panel on Dietetic Products, Nutrition and Allergies (NDA) refutes criticism the agency is biased toward certain nutrients.

Martek reaps regulatory omega-3 benefits

Martek reaps regulatory omega-3 benefits

By Shane Starling in Brussels

DHA omega-3 is one of the few ingredients to benefit from the European Union nutrition and health claims process so far, and Martek's VP of regulatory affairs, Rodney Gray, looks at developments in other regulatory changes that have affected the...

In defence of omega-3

Special comment

In defence of omega-3

The best way to survive a shark attack is to fight back, so say survivors. Events this week suggest the sharks may be beginning to circle the good ship omega-3, and now is the time for industry and academia to start fighting back.

Kemin and DSM commit to article 13.5 lutein submission

Kemin and DSM commit to article 13.5 lutein submission

By Shane Starling

Leading lutein suppler Kemin Health will resubmit a lutein dossier under article 13.5 of the European Union nutrition and health claims regulation, after EFSA last week rejected an article 13.1 lutein-eye health submission.

Differentiation holds the key to antioxidant success: Expert

Special edition: Antioxidants

Differentiation holds the key to antioxidant success: Expert

By Stephen Daniells

In the third part of our series on antioxidants, NutraIngredients talks to Jeff Blumberg, professor of antioxidants at Tuft University, and finds out why we need differentiation in the antioxidant field.

Supply: Beta-carotene club and beyond

Special Edition: Antioxidants

Supply: Beta-carotene club and beyond

By Jane Byrne

In the second part of our antioxidants special, NutraIngredients focuses on the carotenoids where the vitamin A converter, beta-carotene, is still lording it over lutein and lycopene and DSM and BASF’s synthetic versions continue to dominate that particular...

Overview: The (seemingly) unstoppable antioxidant powerhouse

Special edition: Antioxidants

Overview: The (seemingly) unstoppable antioxidant powerhouse

By Shane Starling

In the first instalment of this antioxidants special NutraIngredients scans a diverse global market that has barely been dented by the recession and continues to flourish amid consumer understanding that is often little more than surface deep.

DHA revisions offer hope to health claim rejections

DHA revisions offer hope to health claim rejections

By Stephen Daniells

The affirmation that the omega-3 DHA can benefit cognitive and eye health offers hope to previously rejected claims. And it's business as usual regarding the overall health claims process, despite ratification of the Lisbon Treaty, said a European...